Publications

DrMinzi MS Omary (Mpharm, Msc, PhD)

 

Few Selected Research Publications:

  1. Machado LR, Bowdrey J, Ngaimisi E, Habtewold A, Minzi O, Makonnen E, Yimer G, Amogne W, Mugusi S, Janabi M, Aderaye G, Mugusi F, Viskaduraki M, Aklillu E, Hollox EJ. Copy Number Variation of Fc Gamma Receptor Genes in HIV-Infected and HIV-Tuberculosis Co-Infected Individuals in Sub-Saharan Africa. PLoS One. 2013 Nov 8;8(11):e78165. doi: 10.1371/journal.pone.0078165.
  2. Aklillu E, Odenthal-Hesse L, Bowdrey J, Habtewold A, Ngaimisi E, Yimer G, Amogne W, Mugusi S, Minzi O, Makonnen E, Janabi M, Mugusi F, Aderaye G, Hardwick R, Fu B, Viskaduraki M, Yang F, Hollox EJ. CCL3L1 copy number, HIV load, and immune reconstitution in sub-Saharan Africans. BMC Infect Dis. 2013 Nov 12;13(1):536. [Epub ahead of print]
  3. Ngaimisi E, Habtewold A, Minzi O, Makonnen E, Mugusi S, Amogne W, Yimer G, Riedel KD, Janabi M, Aderaye G, Mugusi F, Bertilsson L, Aklillu E, Burhenne J. Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populations. PLoS One. 2013 Jul 5;8(7):e67946. doi: 10.1371/journal.pone.0067946. Print 2013.
  4. Mghamba FW, Minzi OM, Massawe A, Sasi P. Adherence to antiretroviral therapy among HIV infected children measured by caretaker report, medication return, and drug level in Dar Es Salaam, Tanzania.. BMC Pediatr. 2013 Jun 15;13:95. doi: 10.1186/1471-2431-13-95.
  5. Minzi OM, Marealle IA, Shekalaghe S, Juma O, Ngaimisi E, Chemba M, Rutaihwa M, Abdulla S, Sasi P. Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator's product. Malar J. 2013 May 30;12(1):174. [Epub ahead of print]
  6. Maganda B, Heudi O, Cortinovis A, Picard F, Kretz O, Minzi O. A fast and reliable reversed phase high performance liquid chromatography method for simultaneous determination of selected anti-retroviral and lumefantrine in human plasma.J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Mar 1;919-920:52-60. doi: 10.1016/j.jchromb.2013.01.009. Epub 2013 Jan 19.
  7. Minzi O, Manyilizu V. Application of basic pharmacology and dispensing practice of antibiotics in accredited drug-dispensing outlets in Tanzania.Drug Healthc Patient Saf. 2013;5:5-11. doi: 10.2147/DHPS.S36409. Epub 2013 Jan 30.

Dr Raphael Zozimus Sangeda,

Sangeda RZ, Mosha F, Aboud S, Kamuhabwa A, Chalamilla G, Vercauteren J, et al. Measurement and predictors of adherence to antiretroviral therapy among HIV-infected adults in Tanzania. Manuscr. Prep. 

Sangeda RZ, Mosha F, Aboud S, Vercauteren J, Camacho RJ, van Wijngaerden E, et al. Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings. Manuscr. Prep.

Sangeda RZ, Theys K, Beheydt G, Rhee S-Y, Deforche K, Vercauteren J, et al. HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure. Infect. Genet. Evol. 2013;19:349–60. 

Mosha F, Muchunguzi V, Matee M, Sangeda RZ, Vercauteren J, Nsubuga P, et al. Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania. BMC Public Health 2013;13:38.

Sangeda RZ, Vandepitte J, Huygens A, Van Cleynenbreugel B, Van Poppel H, de Witte PAM. Prevention of tumor cell reimplantation during transurethral resection: the in-vitro antiadhesive and cytotoxic properties of an irrigant containing polyethylene glycol 400. Anticancer. Drugs 2010;21:645–50.

Libin P, Imbrechts S, Beheydt G, Theys K, Sangeda RZ, Camacho RJ, et al. Comparing the prevalence of tipranavir resistance mutations in naive, PI experienced and tipranavir experienced patients. In: 15th International BioInformatics Workshop on Virus Evolution and Molecular Epidemiology,7-11 September 2009, Rotterdam, The Netherlands. 2009.

Assel M, van de Vijver D, Libin P, Theys K, Harezlak D, O Nualláin B, Sangeda RZ,  et al. A collaborative environment allowing clinical investigations on integrated biomedical databases. Stud. Health Technol. Inform. 2009;147:51–61.

 Dr . Joseph Sempombe, PhD.

  • Bugusu C. Nyamweru1; Joseph Sempombe1; Eliangiringa Kaale1,2; Thomas Layloff3. (2013) Development and Validation of a Thin Layer Chromatography Densitometric Method for Analysis of Clotrimazole Vaginal Tablets. Accepted for Publication in Journal of Planar Chromatography - Modern TLC, Manuscript number JPC341R1.
  • Sempombe, Joseph; Stein, Ben; Kirk, Martin L. (2011) Spectroscopic and Electronic Structure Studies Probing Covalency Contributions to C-H Bond Activation and Transition State Stabilization in Xanthine Oxidase. Journal of Inorganic Chemistry 50(21), 10919 - 10928.
  • Sempombe, Joseph; Galinato, Mary Grace I; Elmore, Bradley O. Elmore; Fan, Weihong; Guillemette, Guy; Lehnert, Nicolai; Kirk, Martin L; Feng, Changjian. (2011) Mutation in the FMN Domain Modulates MCD Spectra of the iNOS Ferric Cyano Complex in a Substrate-Specific Manner. Journal of Inorganic Chemistry 50, 6859-6861.
  • Sempombe, Joseph; Elmore, Bradley O; Sun, Xi; Dupont, Andrea; Ghosh, Dipak K; Guillemette, Guy J; Kirk, Martin L; Feng, Changjian. (2009) Mutations in the FMN domain modulate MCD spectra of the heme site in the oxygenase domain of inducible nitric oxide synthase, Journal of the American Chemical Society 131, 6940–6941.
  • Yang, Jing; Rothery, Richard; Sempombe, Joseph; Weiner, Joel H; Kirk Martin L. (2009) Spectroscopic Characterization of YedY: The Role of Sulfur Coordination in a Mo(V) Sulfite Oxidase Family Enzyme Form, Journal of the American Chemical Society 131, 15612–15614.
  • Joseph, C.C.*1, Moshi, M.J.2, Sempombe, J.1 and Nkunya, M.H.H.1(4-Methoxy-Benzo[1,3]Dioxol-5-yl)-phenylmethanone: An Antibacterial Benzophenone from Securidaca longepedunculata, Afr. J. Trad. CAM (2006) 3 (3): 80-86.

 Amani Thomas Mori,

 

1.         Mori AT, Kaale EA, Ngalesoni F, Norheim OF, Robberstad B: The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Countries: The Case of Tanzania. Plos ONE, 2014:9(1): e84824. doi:10.1371/journal.pone.0084824

 

2.         Mori AT, Kaale EA, Risha P: Reforms: A Quest for Efficiency or an Opportunity for Vested Interests? A Case Study of Pharmaceutical Policy Reforms in Tanzania. BMC Public Health, 2013, 13: 651

 

3.         Mori AT, Gavaza P, Robberstad B: The role of Pharmacoeconomics in developing countries.  Farmeconomia. Health economics and therapeutic pathways, 2013; 14(1):3-5

 

4.         Mori AT, Haule AF, Kaale EA: Factors influencing the Persistence of Tobacco Smoking in Public Places in Tanzania: A Cross-sectional Study in Urban, Rural and Semi-rural Settings.Journal of Public Health Frontier 2013; 2(1), pg 77-82.

 

5.         Kaale EA, Mori AT, Risha P, Sakina H, Mwambete K:A retrospective study of poisoning at Muhimbili National Hospital in Dar es Salaam, Tanzania.Journal of Public Health Frontier 2013; 2(1), pg 21-26.

 

6.         Mori AT and Robberstad B: Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review. BMC Medical Informatics and  Decision-making 2012,12 (1):110

 

7.         Mori AT and Kaale EA: Priority setting in the implementation of Artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework. Implementation science 2012, 7 (1): 18

 

8.         Matowe L, Mori AT, Mawa S: Enhancing the role of pharmacists in public health in developing countries.The Pharmaceutical Journal 2012; 288 (1)

 

9.         Matowe L and Mori AT: Time to be counted: Pharmacist as a key untapped resource for public health in developing countries.Equinet Newsletter 2012: 137  

 

 

Dr. Eliford Ngaimisi Kitabi,

1.       Machado LR, Bowdrey J, Ngaimisi E, Habtewold A, Minzi O, Makonnen E, Yimer G, Amogne W, Mugusi S, Janabi M, Aderaye G, Mugusi F, Viskaduraki M, Aklillu E, Hollox EJ. Copy Number Variation of Fc Gamma Receptor Genes in HIV-Infected and HIV-Tuberculosis Co-Infected Individuals in Sub-Saharan Africa. PLoS One. 2013 Nov 8; 8(11):e78165. doi: 10.1371/journal.pone.0078165.

2.       Aklillu E, Odenthal-Hesse L, Bowdrey J, Habtewold A, Ngaimisi E, Yimer G, Amogne W, Mugusi S, Minzi O, Makonnen E, Janabi M, Mugusi F, Aderaye G, Hardwick R, Fu B, Viskaduraki M, Yang F, Hollox EJ. CCL3L1 copy number, HIV load, and immune reconstitution in sub-Saharan Africans. BMC Infect Dis. 2013 Nov 12; 13(1):536.

 

3.       Pillai G, Davies G, Denti P, Steimer JL, McIlleron H, Zvada S, Chigutsa E, Ngaimisi E, Mirza F, Tadmor B, Holford NH. Pharmacometrics: opportunity for reducing disease burden in the developing world: the case of Africa. CPT Pharmacometrics Syst Pharmacol. 2013 Aug 28;2:e69. doi: 10.1038/psp.2013.45.

4.       Ngaimisi E, Habtewold A, Minzi O, Makonnen E, Mugusi S, Amogne W, Yimer G, Riedel KD, Janabi M, Aderaye G, Mugusi F, Bertilsson L, Aklillu E, Burhenne J. Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populations. PLoS One. 2013 Jul 5;8(7):e67946. doi: 10.1371/journal.pone.0067946.

5.       Minzi OM, Marealle IA, Shekalaghe S, Juma O, Ngaimisi E, Chemba M, Rutaihwa M, Abdulla S, Sasi P. Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator's product. Malar J. 2013 May 30;12(1):174.

6.       Hardwick RJ, Amogne W, Mugusi S, Yimer G, Ngaimisi E, Habtewold A, Minzi O, Makonnen E, Janabi M, Machado LR, Viskaduraki M, Mugusi F, Aderaye G, Lindquist L, Hollox EJ, Aklillu E. β-defensin genomic copy number is associated with HIV load and immune reconstitution in sub-saharan Africans. J Infect Dis. 2012 Oct 1;206(7):1012-9.

7.       Mugusi S, Ngaimisi E, Janabi M, Minzi O, Bakari M, Riedel KD, Burhenne J, Lindquist L, Mugusi F, Sandstrom E, Aklillu E. Liver enzyme abnormalities and associated risk factors in HIV patients on efavirenz-based HAART with or without tuberculosis co-infection in Tanzania. PLoS One. 2012;7(7):e40180.

8.       Mugusi SF, Ngaimisi E, Janabi MY, Mugusi FM, Minzi OM, Sasi PG, Bakari M, Lindquist L, Aklillu E, Sandstrom EG. Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania. Antivir Ther. 2012;17(2):265-74.

9.       Ngaimisi E, Mugusi S, Minzi O, Sasi P, Riedel KD, Suda A, Ueda N, Janabi M, Mugusi F, Haefeli WE, Bertilsson L, Burhenne J, Aklillu E. Effect of rifampicin and CYP2B6 genotype on long-term efavirenz autoinduction and plasma exposure in HIV patients with or without tuberculosis. Clin Pharmacol Ther. 2011 Sep;90(3):406-13.

10.   Eliford Ngaimisi, Emmanuel Chigutsa, Gangadhar Sunkara, Les Choi, Thomas Bouillon, Xuemin Jiang. Population Pharmacokinetics of Oral Salmon Calcitonin in Healthy Postmenopausal Women. Poster presented at the D&I Novartis Open Day, 28 September 2011, Basel, Switzerland

 

11.   Aklillu E, Mugusi S, Ngaimisi E, Hoffmann MM, König S, Ziesenitz V, Mikus G, Haefeli WE, Weiss J. Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler®-based method. Eur J Clin Pharmacol. 2011 Nov; 67(11):1139-45.

12.   Ngaimisi E, Mugusi S, Minzi OM, Sasi P, Riedel KD, Suda A, Ueda N, Janabi M, Mugusi F, Haefeli WE, Burhenne J, Aklillu E. Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients. Clin Pharmacol Ther. 2010 Nov;88(5):676-84.

12.

13.   Omary M. S. Minzi and Eliford Ngaimisi.Bioanalytical method for determination of Nevirapine in-vivo in resource constrained laboratories. J. Chem. Pharm. Res., 2010, 2(2): 431-439.

 

 

 Dr. Eliangiringa Kaale

Publications

A.     Books

1         Chapter in a Book: Kaale, E.; Risha, P.  Layloff, T. ; Sherma, J. Screening of Substandard and Fake Drugs in Underdeveloped Countries by TLC. In Thin Layer Chromatography in Drug Analysis, Komsta, L; Waksmundzka-Hajnos, M.; Sherma, J. (Eds.), CRC Press/Taylor & Francis Group, Boca Raton, FL, . ISBN-13: 978-1-4665-0715-9, December 26, 2013 by CRC Press

 B: Journal articles

 

1         Bugusu C. Nyamweru, Joseph Sempombe, Eliangiringa Kaale, Thomas Layloff Development and Validation of a Thin Layer Chromatography Densitometric Method for Analysis of Clotrimazole Vaginal Tablets, In press 2013

2         Mori AT, Kaale EA, Ngalesoni F, Norheim OF, Robberstad B: The Role of Evidence in the Decision-Making Process of Selecting Essential Medicines in Developing Countries: The Case of Tanzania PLOS ONE, In press ,2013

3         Mori AT, Kaale EA, Risha P. Reforms: a quest for efficiency or an opportunity for vested interests'? A case study of pharmaceutical policy reforms in Tanzania. BMC Public Health. 2013 Jul 13;13:651. doi: 10.1186/1471-2458-13-651.

4         Eliangiringa Kaale, Bugusu C. Nyamweru, Vicky Manyanga, Mhina Chambuso, Thomas Layloff , The development and validation of a Thin Layer Chromatography densitometry method for the analysis of diclofenac sodium tablets, DOI: 10.1016/j.ijcas.2013.05.001

5         A.T. Mori , E. A. Kaale, A Haule, Factors Influencing the Persistence of Tobacco Smoking in Public Places in Tanzania: A Cross-Sectional Study in Urban, Rural and Semi-Rural Settings, Journal of Public Health Frontier Jun. 2013, Vol. 2 Iss. 2, PP. 77-82

6         Bugusu C. Nyamweru, Eliangiringa Kaale, Vicky P. Manyanga, Mhina Chambuso, and Thomas Layloff, Development and Validation of a Thin-Layer Chromatographic–Densitometric Method for the Analysis of Ciprofloxacin Hydrochloride Tablets, Journal of Planar C,hromatography 26 (2013) 4, 370–374, DOI: 10.1556/JPC.26.2013.4.14

7         E. Kaale, A. Mori, P. Risha, S. Hasham, K. Mwambete, A Retrospective Study of Poisoning at Muhimbili National Hospital in Dar-Es Salaam, Tanzania, Journal of Public Health Frontier Mar. 2013, Vol. 2 Iss. 1, PP. 21-26

8         Bugusu C. Nyamweru, Eliangiringa Kaale, Veronica Mugoyela, and Mhina Chambuso, Development and Validation of an HPTLC–Densitometric Method for Simultaneous Analysis of Lamivudine, Tenofovir Disoproxil Fumarate, and Efavirenz (LTE) in Tablets, Journal of Planar Chromatography 26 (2013) 3, 226–231 DOI: 10.1556/JPC.26.2013.3.4

9         Shewiyo DH, Kaale E, Risha PG, Dejaegher B, De Beer J, Smeyers-Verbeke J, Vander Heyden Y.  Accuracy profiles assessing the validity for routine use of high-performance thin-layer chromatographic assays for drug formulations. J Chromatogr A. 2013 Jun 7;1293:159-69. doi: 10.1016/j.chroma.2013.03.074. Epub 2013 Apr 8.

10     Shewiyo DH, Kaale E, Risha PG, Dejaegher B, Smeyers-Verbeke J, Vander Heyden Y. Optimization of a reversed-phase-high-performance thin-layer chromatography method for the separation of isoniazid, ethambutol, rifampicin and pyrazinamide in fixed-dose combination antituberculosis tablets. J Chromatogr A. 2012 Oct 19;1260:232-8. doi: 10.1016/j.chroma.2012.08.044. Epub 2012 Aug 3

11     Shewiyo DH, Kaale E, Risha PG, Dejaegher B, Smeyers-Verbeke J, Heyden YV. HPTLC methods to assay active ingredients in pharmaceutical formulations: A review of the method development and validation steps. J Pharm Biomed Anal. 2012 Jul;66:11-23. Epub 2012 Mar 28.

12     Mori AT, Kaale EA. Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework. Implement Sci. 2012 Mar 18;7(1):18. [Epub ahead of print]

13     D. H. Shewiyo, E. Kaale, P. G. Risha, H. Sillo, B. Dejaegherc, J. Smeyers – Verbeke, Y. Vander Heyden, Development and validation of a normal-phase HPTLC-densitometric method for the quantitative analysis of fluconazole in tablets, Journal of Planar Chromatography 24 (2011) 6, 529–533.

14     E. Kaale, Peter Risha and Thomas Layloff, “TLC for pharmaceutical analysis in resource limited countries” J Chromatogr A. 2010 Dec 13. [Epub ahead of print].

15     E. Kaale, Peter Risha, Eike Reich, and Thomas P. Layloff.  An Inter-laboratory Investigation on the Use of High Performance Thin Layer Chromatography to Perform Assays of Lamivudine-Zidovudine, Metronidazole, Nevirapine, and Quinine Composite Samples, JOURNAL OF AOAC INTERNATIONAL VOL. 93, NO. 6, 2010

16     Shewiyo DH, Kaale E, Ugullum C, Sigonda MN, Risha PG, Dejaegher B, Smeyers-Verbeke J, Heyden YV. Development and validation of a normal-phase HPTLC method for the simultaneous analysis of lamivudine, stavudine and nevirapine in fixed-dose combination tablets. Journal of Pharmaceutical and Biomedical Analysis 54 (2011) 445–450

17     Shewiyo DH, Kaale E, Risha PG, Dejaegher B, Smeyers-Verbeke J, Vander Heyden Y., Development and validation of a normal-phase high-performance thin layer chromatographic method for the analysis of Sulfamethoxazole and trimethoprim in co-trimoxazole tablets. J Chromatogr A. 2009 Oct 16; 1216(42):7102-7.

18     Kaale, E. Haule, A. F, Mung’ong’o S., Kishiwa M., Evaluation of quality of hydrogen peroxide based antiseptic solutions available in Dar es salaam, Tanzania,  Journal of Clinical Pharmacy and Therapeutics, 32, 613-616, 2007

19     Kaale, E. Chambuso, M. Kitwala, J Analysis of residual Oxytetracycline in fresh milk using Polymer reversed-phase column, Food Chemistry,  107, 1289-1293, 2008.

20     Kaale, E., Malele RS., Maganda B., Awareness of secondary school students on various gender perspective programmes conducted by the University of Dar es Salaam, Tanzania. Zimbabwe Journal of Educational Research, Volume 19 , Number 3, 2007.  

 

21     Anyakudo, F., Kaale, E., Govaerts, C., Van Schepdael, A. Hoogmartens, J. Determination of amikacin  in bulk pharmaceutical samples by micellar electrokinetic capillary chromatography with UV detection, Trends in Chromatography, 2006 , 1, 95-103."

22     Kaale E, Govaerts C, Van Schepdael A, Hoogmartens, J, Mass spectrometric study to characterize  thioindole derivatives aminoglycoside antibiotics,  Rapid Communication in mass Spectrometry 2005 Sept 19: 2918-2922

23     Kaale E, Long, Y, Van Schepdael A, Roets E, Hoogmartens, J. Gentamicin assay in human serum by Solid-phase extraction capillary electrophoresis, Electrophoresis 2005, Feb; 26(3): 640-7.

24     Fonge H, Kaale E, Govaerts C, Desmet K, Van Schepdael A, Hoogmartens, Bioanalysis of Tobramycin for Therapeutic Drug Monitoring by Solid-Phase Extraction and Capillary Zone Electrophoresis: Confirmation by Mass Spectrometry, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2004, 810, :313-8.

25     Van Dyck S, Kaale E, Nováková S, Glatz Z, Hoogmartens J, and Van Schepael A, Advances in Capillary Electrophoretically Mediated Microanalysis, Electrophoresis. 2003, 24 3868-78.

26     Kaale E, Van Schepdael A, Roets E, Hoogmartens J., Determination of Kanamycin by electrophoretically mediated microanalysis and UV detection. Electrophoresis 2003, 24,1119-1125.

27     Long, Y., Hernandez, M., Kaale E, Van Schepdael A, Roets E, Bourrul, F., Calull, M., Hoogmartens, J. Determination of kanamycin in serum by solid-phase extraction, pre-capillary derivatization and capillary electrophoresis, with UV detection, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2003, 784, 255-264.

28     Kaale E, Van Schepdael A, Roets E, Hoogmartens J., Determination of capsaicinoids in topical cream by liquid–liquid extraction and liquid chromatography, Journal of Pharmaceutical and Biomedical Analysis, 30, 2002, 1331-1337. Vague

29     Kaale E, Van Schepdael A, Roets E, Hoogmartens, Determination of Tobramycin by electrophoresis, Bioforum International 5, 2002, 271-274.

30     Kaale E, Van Schepdael A, Roets E, Hoogmartens J., Aminoglycoside antibiotics: A decade overview of capillary electrophoretic analysis, American Laboratory News, 34, 22-26 2002.

31     Kaale E, Van Schepdael A, Roets E, Hoogmartens J., Optimization of a pre-capillary protocol for derivatization for tobramycin with CE and UV detection, Journal de Pharmacie de Belgique Hors sèrie 1, 20-22 2002.

32     Kaale E, Van Schepdael A, Roets E, Hoogmartens J Development and validation of capillary electrophoresis method for tobramycin with precapillary derivatization and UV detection, Electrophoresis, 23, 1695-1701 2002.

33     Kaale E, Van Schepdael A, Roets E, Hoogmartens J, Development and validation of a simple capillary zone electrophoresis method for the analysis of kanamycin sulfate with UV detection after pre-capillary derivatization, Journal of Chromatography A, 924, 451-458, 2001.

34     Kaale E, Van Goidsenhoven E, Van Schepdael A, Roets E, Hoogmartens J Electrophoretically mediated microanalysis of gentamicin with in-capillary derivatization and UV detection, Electrophoresis, 22, 2746-2754 2001.

35     Kaale E, Leonard S, Van Schepdael A, Roets E, Hoogmartens J, Capillary Electrophoresis analysis of gentamicin sulphate with UV detection after pre-capillary derivatization with 1,2-phthalic dicarboxaldehyde and mercaptoacetic acid, Journal of Chromatography A, 895, 67-79 20 2000.

36     Mgoyela V., Kagashe G., Kabati C., and Kaale E.: Antimalarial drugs prescribing practice in four private dispensaries based in Dar es Salaam. East and Central African Journal of Pharmaceutical Sciences, Vol.2 No. 2. 1999, pp 29-31

 

INVITED ORAL PRESENTATION

  1. E. Kaale "The Pharm R&D laboratory: Model technology transfer center to support local pharmaceutical manufacturers in ARV formulation development" presented at ‘’The 16th Scientific Congress of the Association of the Colleges of Pharmacy in the Arab World; Benghazi, Libya Nov 4-7th 2013 Retrievable http://www.academyih.org/conferences/uploads/keynote_speakers.htm
  2. Dr. Eliangiringa Kaale Title Quality Impact in the Light of Shortage of Human Resources, International Conference Local Production and Access to Medicines 21 February 2013, Gustav-Stresemann Institute, Bonn/Germany Retrievable http://medeor.de/images/themen/konferenz/EliangiringaKaale.pdf
  3. Dr. Eliangiringa Kaale Title ‘’Pharm R&D Laboratory: Model Technology Transfer To Support Local Pharmaceutical Manufacturers In Formulation Development,’’ African Network For Drugs And Diagnostics Innovation, 4th Stakeholder Meeting, 27 -27 October 2011, United Nations Conference, Centre, Addis Ababa, Ethiopia
  4. Dr. Eliangiringa Kaale , Title ‘’Sustainable Ict Platform To Support Coordination In Health Data Management In Africa’’, African Network For Drugs And Diagnostics Innovation, 4th Stakeholder Meeting, 27 -27 October 2011, United Nations Conference Centre, Addis Ababa, Ethiopia
  5. Dr. Eliangiringa Kaale  Title ‘’TLC  For Pharmaceutical Analysis In Resource Limited Countries” At HPTLC 2011: International Symposium For Thin-Layer Chromatography, Basel, Switzerland -6-9th July 2011
  6. Dr. Eliangiringa Kaale  Title ‘’Establishment  of  A Teaching Pharmaceutical R&D Laboratory To Support Domestic Pharmaceutical Manufacturers To Improve Product Quality’ ’International Conference On Local Pharmaceutical Production In Africa” 3rd To 7th April 2011 Cape Town, RSA
  7. Dr. Eliangiringa Kaale, Title “Pharmaceutical Firms And Standards: African Experiences”, Science With Africa 2 Conference June 22-26 2010, Organized By United Nation Economic

 

 

 

Contact US

SCHOOL OF PHARMACY
P.O. Box 65013
Dar es Salaam
Tel: Direct: +255-22-2151680, Tel: +255 22 2150302-6 (Ext. 1008 Dean, 1276 OMS)
Fax: +255-022-2150465
E-Mail dspha@muhas.ac.tz